Medicinal herbs for hepatitis C virus infection.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  2001-10-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.CD003183PMID 11687177PMCID PMC6669271
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ribavirin plus interferon versus interferon for chronic hepatitis C.

  2010cited by this paper
• Alcoholic hepatitis - glucocorticosteriods or not?

  2002cited by this paper
• Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses

  2001cited by this paper
• Toxicity of Complementary Therapies: An Eastern Perspective

  2000cited by this paper
• Recent advances: complementary medicine.

  2000cited by this paper
• 45-Year Follow-up of Hepatitis C Virus Infection in Healthy Young Adults

  2000cited by this paper
• [Pathological study of the therapeutic effect of compound qinggan granula on chronic hepatitis C].

  2000cited by this paper
• Gynaecologist banned in Canada appears before GMC

  2000cited by this paper
• Treatment of chronic liver diseases with traditional Chinese medicine

  2000cited by this paper
• Consensus among consensus conferences on management of hepatitis C: What we knew then and are still sure about, what we are newly sure about, and what we still need to know

  2000cited by this paper
• The natural history of hepatitis C virus infection: host, viral, and environmental factors.

  2000cited by this paper
• Intravenous glycyrrhizin for the treatment of chronic hepatitis C: A double‐blind, randomized, placebo‐controlled phase I/II trial

  1999cited by this paper
• Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients.

  1999cited by this paper
• Herbal products for liver diseases: A therapeutic challenge for the new millennium

  1999cited by this paper
• Persistence of viremia and the importance of long‐term follow‐up after acute hepatitis C infection

  1999cited by this paper
• Liver enzyme elevations in patients treated with traditional Chinese medicine.

  1999cited by this paper
• Sho‐saiko‐to: The right blend of traditional oriental medicine and liver cell biology

  1999cited by this paper
• Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks.

  1999cited by this paper
• Effect of Gansu Capsule on Chronic Hepatitis C

  1999cited by this paper
• Effectiveness of the analogue of natural Schisandrin C (HpPro) in treatment of liver diseases: an experience in Indonesian patients.

  1998cited by this paper
• Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey.

  1998cited by this paper
• Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

  1998cited by this paper
• A review of 12 commonly used medicinal herbs.

  1998cited by this paper
• Oral Thymic Extract for Chronic Hepatitis C in Patients Previously Treated with Interferon

  1998cited by this paper
• glycyrrhizin as a potential treatment for chronic hepatitis C

  1998cited by this paper
• Do certain countries produce only positive results? A systematic review of controlled trials.

  1998cited by this paper
• Preliminary report of a randomized, double‐blind placebo‐controlled trial of a Chinese herbal medicine preparation CH‐100 in the treatment of chronic hepatitis C

  1998cited by this paper
• Hepatitis C: The clinical spectrum of disease

  1997cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• The long term efficacy of glycyrrhizin in chronic hepatitis C patients

  1997cited by this paper
• Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.

  1997cited by this paper
• The Ayurvedic drug LIV.52 in patients with alcoholic cirrhosis. Results of a prospective, randomized, double-blind, placebo-controlled clinical trial

  1997cited by this paper
• Epidemiology of hepatitis C

  1997cited by this paper
• The pharmacokinetics of glycyrrhizin and its restorative effect on hepatic function in patients with chronic hepatitis and in chronically carbon‐tetrachloride‐intoxicated rats

  1997cited by this paper
• Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection

  1996cited by this paper
• Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis.

  1996cited by this paper
• Assessing the quality of reports of randomized clinical trials: is blinding necessary?

  1996cited by this paper
• Histological grading and staging of chronic hepatitis.

  1995cited by this paper
• Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.

  1995cited by this paper
• Persistent hepatitis C viremia after acute self‐limiting posttransfusion hepatitis C

  1995cited by this paper
• Histological grading and staging of chronic hepatitis.

  1995cited by this paper
• [Efficacy of interferon combined glycyrrhizin therapy in patients with interferon-resistant chronic hepatitis C].

  1994cited by this paper
• [Efficacy of interferon combined glycyrrhizin therapy in patients with chronic hepatitis C resistant to interferon therapy].

  1994cited by this paper
• [Effectiveness of interferon, glycyrrhizin combination therapy in patients with chronic hepatitis C].

  1994cited by this paper
• Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis.

  1993cited by this paper
• A pilot study on the liver protective effect of silybin-phosphatidylcholine complex (IdB1016) in chronic active hepatitis.

  1993cited by this paper
• The natural history of community-acquired hepatitis C in the United States.

  1992cited by this paper
• The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.

  1992cited by this paper
• A long-term study of hepatitis C virus replication in non-A, non-B hepatitis.

  1991cited by this paper
• Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver.

  1989cited by this paper
• Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

  1989cited by this paper
• A multicenter randomized controlled clinical trial of Shosaiko-to in chronic active hepatitis

  1989cited by this paper
• Effects of a Preparation Containing a Standardized Ginseng Extract Combined with Trace Elements and Multivitamins against Hepatotoxin-induced Chronic Liver Disease in the Elderly

  1987cited by this paper
• Harwood Academic Publishers imprint, part of Gordon and Breach Publishing Group Printed in Malaysia Effects of the Japanese Herbal Medicine "Sho-saiko-to" (TJ-9) on Interleukin-12 Production in Patients with HC-Positive Liver Cirrhosis

  year unknowncited by this paper

• Knowledge of hepatitis C and awareness of reinfection risk among people who successfully completed direct acting antiviral therapy

  2022cites this paper
• Systems pharmacology: a combination strategy for improving efficacy of PD-1/PD-L1 blockade

  2021cites this paper
• Fighting antimicrobial resistance (AMR): Chinese herbal medicine as a source of novel antimicrobials – an update

  2021cites this paper
• The Cochrane Review Conclusion for Hepatitis C DAA Therapies is Wrong

  2018cites this paper
• Phytochemicals in Clinical Studies: Current Perspective

  2018cites this paper
• List herbal therapies ( Check all that apply ) : Dandelion root Echinacea Evening primrose oil Ginkgo biloba Ginseng Glucosamine Sulphate Licorice Milk Thistle

  2016cites this paper
• After HCV Eradication with Sovaldiî, Can Herbs Regenerate Damaged Liver, Minimize Side Effects and Reduce the Bill?

  2016cites this paper
• Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders.

  2015cites this paper
• Safety and efficacy of Qurse-e-istisqua in chronic hepatitis C Infection: An exploratory study

  2015cites this paper
• Clinical recommendations of Cochrane reviews in pediatric gastroenterology: Systematic analysis

  2015cites this paper
• Pacient s onemocněním jater a žlučníku v lékárně

  2015cites this paper
• Pharmacological treatments for chronic hepatitis C liver disease: a network meta-analysis

  2015cites this paper
• Study of Hepatoprotective Effect of Silymarin and Ursodeoxycholic Acid in Chronic Hepatitis C Patients

  2014cites this paper
• Systematic reviews in the field of complementary and alternative medicine: importance, methods and examples concerning acupuncture

  2013cites this paper
• Differential In Vitro Effects of Intravenous versus Oral Formulations of Silibinin on the HCV Life Cycle and Inflammation

  2011cites this paper
• Zebrafish as a Potential Model Organism for Drug Test Against Hepatitis C Virus

  2011cites this paper
• Biological analysis of herbal medicines used for the treatment of liver diseases.

  2011cites this paper
• Cochrane Systematic Reviews of Chinese Herbal Medicines: An Overview

  2011cites this paper
• Antioxidant and antiviral activities of silybin fatty acid conjugates.

  2010cites this paper
• An antioxidant resveratrol significantly enhanced replication of hepatitis C virus.

  2010cites this paper
• Complementary and Alternative Medicine

  2010cites this paper
• Medicinal herbs for hepatitis C virus infection (Review)

  2009influential citation
• Pharmacological interventions for ischaemia reperfusion injury in liver resection surgery performed under vascular control.

  2009cites this paper
• Evidence from the Cochrane Collaboration for Traditional Chinese Medicine Therapies

  2009cites this paper
• Complementary and alternative medicine use by patients chronically infected with hepatitis C virus.

  2007cites this paper
• Hepatitis C: Epidemiology, Diagnosis, and Management

  2007cites this paper
• Antioxidant therapy for chronic hepatitis C after failure of interferon: results of phase II randomized, double-blind placebo controlled clinical trial.

  2007cites this paper
• Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well‐being in patients with chronic hepatitis C

  2006cites this paper
• American Gastroenterological Association technical review on the management of hepatitis C.

  2006cites this paper
• Randomized double blind placebo‐controlled trial of a Chinese herbal therapy (CH100) in chronic hepatitis C

  2006cites this paper
• Silymarin treatment of viral hepatitis: a systematic review

  2005cites this paper
• Complementary and alternative medicine in the treatment of chronic liver disease

  2005cites this paper
• Oral silymarin for chronic hepatitis C - a retrospective analysis comparing three dose regimens.

  2005cites this paper
• Braised liver with herbs: the risks of naturopathic hepatoprotection.

  2005cites this paper
• Agreement between reported use of interventions for liver diseases and research evidence in Cochrane systematic reviews.

  2005cites this paper
• A randomized trial of Chinese herbal medicines for the treatment of symptomatic hepatitis C.

  2004influential citation
• Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results.

  2004cites this paper
• Severe acute respiratory syndrome (SARS)—paradigm of an emerging viral infection

  2003cites this paper
• Medicinal Herbs for Hepatitis C Virus Infection: A Cochrane Hepatobiliary Systematic Review of Randomized Trials

  2003cites this paper
• Editorial Acute, serious drug-induced liver injury

  2002cites this paper
• Acute, serious drug-induced liver injury.

  2002cites this paper
• Alternative Therapiestrategien chronischer Virushepatitiden

  2002cites this paper
• Understudied populations with hepatitis C

  2002cites this paper